1H-1,2,3-Triazole → 6-methyl-3-(2H-1,2,3-triazol-2-yl)picolinic acid

HRID 61101

반응식

HRID 61101 반응식
[CH3:1][C:2]1[N:7]=[C:6]([C:8]([OH:10])=[O:9])[C:5]([N:11]2C=[CH:14][CH:13]=[N:12]2)=[CH:4][CH:3]=1.[N:16]1NN=CC=1>>[CH3:1][C:2]1[N:7]=[C:6]([C:8]([OH:10])=[O:9])[C:5]([N:11]2[N:12]=[CH:13][CH:14]=[N:16]2)=[CH:4][CH:3]=1

참가 물질

3

반응물 2

HCID 675161H-1,2,3-TriazoleHCID 593636726-Methyl-3-(1H-pyrazol-1-yl)picolinic acid

생성물 1

HCID 593637336-methyl-3-(2H-1,2,3-triazol-2-yl)picolinic acid

실험 절차

The title compound was prepared following the same general protocol as described for 6-methyl-3-(1H-pyrazol-1-yl)picolinic acid in Example A164, using 2H-1,2,3-triazole. ESI-MS (m/z): 205 [M+1]+.

출처 및 근거

ORD 기록
ord-5d7d9345f37b4f179f8b85ff1033be17
출처 데이터셋
uspto-grants-2016_09
특허 번호
US09440982B2

연결된 노트

불러오는 중…